Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis. Harari D, Kuhn N, Abramovich R, Sasson K, Zozulya A, Smith P, Schlapschy M, Aharoni R, Köster M, Eliam R, et al. J Biol Chem. 2014 Sep 5. PMID: 25193661. Abstract CommentRecommendBookmarkWatch